KEYWORD INDEX

Click on the first letter of the keyword:
 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Search results for: "T"
Results 91 - 100 of 122 shown below
treatment
David W Oslin, Wade Berrettini, Henry R Kranzler, Helen Pettinati, Joel Gelernter, Joseph R Volpicelli and Charles P O'Brien
A Functional Polymorphism of the mu-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients
doi:10.1038/sj.npp.1300219
Neuropsychopharmacology 28, 1546-1552

Abstract | Full text | PDF |
Raquel E Gur, Christian Kohler, J Daniel Ragland, Steven J Siegel, Warren B Bilker, James Loughead, Nick Phend and Ruben C Gur
Neurocognitive Performance and Clinical Changes in Olanzapine-Treated Patients with Schizophrenia
doi:10.1038/sj.npp.1300275
Neuropsychopharmacology 28, 2029-2036

Abstract | Full text | PDF |
Margaret Haney, Carl L Hart, Suzanne K Vosburg, Jennifer Nasser, Andrew Bennett, Carlos Zubaran and Richard W Foltin
Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex
doi:10.1038/sj.npp.1300310
Neuropsychopharmacology 29, 158-170

Abstract | Full text | PDF |
John Grabowski, Howard Rhoades, Angela Stotts, Katherine Cowan, Charles Kopecky, Anne Dougherty, F Gerard Moeller, Sohela Hassan and Joy Schmitz
Agonist-Like or Antagonist-Like Treatment for Cocaine Dependence with Methadone for Heroin Dependence: Two Double-Blind Randomized Clinical Trials
doi:10.1038/sj.npp.1300392
Neuropsychopharmacology 29, 969-981

Abstract | Full text | PDF |
Gerard Sanacora, Robert M Berman, Angela Cappiello, Dan A Oren, Akira Kugaya, Nianjun Liu, Ralitza Gueorguieva, Donna Fasula and Dennis S Charney
Addition of the alpha2-Antagonist Yohimbine to Fluoxetine: Effects on Rate of Antidepressant Response
doi:10.1038/sj.npp.1300418
Neuropsychopharmacology 29, 1166-1171

Abstract | Full text | PDF |
John Beyer, Maragatha Kuchibhatla, Kenneth Gersing and K Ranga R Krishnan
Medical Comorbidity in a Bipolar Outpatient Clinical Population
doi:10.1038/sj.npp.1300608
Neuropsychopharmacology 30, 401-404

Abstract | Full text | PDF |
Caryn Lerman, Christopher Jepson, E Paul Wileyto, Leonard H Epstein, Margaret Rukstalis, Freda Patterson, Vyga Kaufmann, Stephanie Restine, Larry Hawk, Ray Niaura and Wade Berrettini
Role of Functional Genetic Variation in the Dopamine D2 Receptor (DRD2) in Response to Bupropion and Nicotine Replacement Therapy for Tobacco Dependence: Results of Two Randomized Clinical Trials
doi:10.1038/sj.npp.1300861
Neuropsychopharmacology 31, 231-242

Abstract | Full text | PDF |
Daniel J Buysse, David J Kupfer, Christine Cherry, Deborah Stapf and Ellen Frank
Effects of Prior Fluoxetine Treatment on EEG Sleep in Women with Recurrent Depression
doi:10.1016/S0893-133X(99)00025-1
Neuropsychopharmacology 21, 258-267

Abstract | Full text | PDF |
Brian Kirkpatrick, Alex Kopelowicz, Robert W Buchanan and William T Carpenter
Assessing the Efficacy of Treatments for the Deficit Syndrome of Schizophrenia
doi:10.1016/S0893-133X(99)00122-0
Neuropsychopharmacology 22, 303-310

Abstract | Full text | PDF |
Steven J Siegel, Karen I Winey, Raquel E Gur, Robert H Lenox, Warren B Bilker, Debbie Ikeda, Neel Gandhi and Wen-Xiao Zhang
Surgically Implantable Long-term Antipsychotic Delivery Systems for the Treatment of Schizophrenia
doi:10.1016/S0893-133X(01)00426-2
Neuropsychopharmacology 26, 817-823

Abstract | Full text | PDF |
treatment adherence
Farzin Irani, Mary Dankert, Colleen Brensinger, Warren B Bilker, Sudha R Nair, Christian G Kohler, Stephen J Kanes, Bruce I Turetsky, Paul J Moberg, John D Ragland, Ruben C Gur, Raquel E Gur and Steven J Siegel
Patient Attitudes towards Surgically Implantable, Long-Term Delivery of Psychiatric Medicine
doi:10.1038/sj.npp.1300385
Neuropsychopharmacology 29, 960-968

Abstract | Full text | PDF |
Treatment outcome
David Roll, Susan E Ray, Sue M Marcus, Vincent Passarelli, Roy Money, David H Barlow, Scott W Woods, M Katherine Shear and Jack M Gorman
Independent Evaluator Knowledge of Treatment in a Multicenter Comparative Treatment Study of Panic Disorder
doi:10.1038/sj.npp.1300373
Neuropsychopharmacology 29, 612-618

Abstract | Full text | PDF |
Thomas R Kosten, Barbara Ellen Scanley, Karen A Tucker, Alison Oliveto, Chekema Prince, Rajita Sinha, Marc N Potenza, Pawel Skudlarski and Bruce E Wexler
Cue-Induced Brain Activity Changes and Relapse in Cocaine-Dependent Patients
doi:10.1038/sj.npp.1300851
Neuropsychopharmacology 31, 644-650

Abstract | Full text | PDF |
Gerard E Bruder, Michael W Otto, Patrick J McGrath, Jonathan W Stewart, Maurizio Fava, Jerrold F Rosenbaum and Frederic M Quitkin
Dichotic Listening before and after Fluoxetine Treatment for Major Depression: Relations of Laterality to Therapeutic Response
doi:10.1016/0893-133X(95)00180-L
Neuropsychopharmacology 15, 171-179

PDF |
Frederic M Quitkin, Patrick J McGrath, Jonathan W Stewart, Bonnie P Taylor and Donald F Klein
Can the Effects of Antidepressants Be Observed in the First Two Weeks of Treatment?
doi:10.1016/0893-133X(95)00272-F
Neuropsychopharmacology 15, 390-394

Abstract | PDF |
Randi Taylor, Alan G Mallinger, Ellen Frank, Paola Rucci, Michael E Thase and David J Kupfer
Variability of Erythrocyte and Serum Lithium Levels Correlates with Therapist Treatment Adherence Efforts and Maintenance Treatment Outcome
doi:10.1016/S0893-133X(00)00200-1
Neuropsychopharmacology 24, 192-197

Abstract | Full text | PDF |
Treatment response
Julie B Schweitzer, Douglas O Lee, Russell B Hanford, Malle A Tagamets, John M Hoffman, Scott T Grafton and Clinton D Kilts
A Positron Emission Tomography Study Of Methylphenidate in Adults with ADHD: Alterations in Resting Blood Flow and Predicting Treatment Response
doi:10.1038/sj.npp.1300110
Neuropsychopharmacology 28, 967-973

Abstract | Full text | PDF |
Younger W-Y Yu, Tai-Jui Chen, Chen-Jee Hong, Hung-Mei Chen and Shih-Jen Tsai
Association Study of the Interleukin-1beta (C-511T) Genetic Polymorphism with Major Depressive Disorder, Associated Symptomatology, and Antidepressant Response
doi:10.1038/sj.npp.1300172
Neuropsychopharmacology 28, 1182-1185

Abstract | Full text | PDF |
Gerard E Bruder, Jonathan W Stewart, Patrick J McGrath, Deborah Deliyannides and Frederic M Quitkin
Dichotic Listening Tests of Functional Brain Asymmetry Predict Response to Fluoxetine in Depressed Women and Men
doi:10.1038/sj.npp.1300519
Neuropsychopharmacology 29, 1752-1761

Abstract | Full text | PDF |
Guy G Potter, Joshua D Kittinger, H Ryan Wagner, David C Steffens and K Ranga Rama Krishnan
Prefrontal Neuropsychological Predictors of Treatment Remission in Late-Life Depression
doi:10.1038/sj.npp.1300551
Neuropsychopharmacology 29, 2266-2271

Abstract | Full text | PDF |
Thomas C Baghai, Flavia di Michele, Cornelius Schüle, Daniela Eser, Peter Zwanzger, Augusto Pasini, Elena Romeo and Rainer Rupprecht
Plasma Concentrations of Neuroactive Steroids before and after Electroconvulsive Therapy in Major Depression
doi:10.1038/sj.npp.1300684
Neuropsychopharmacology 30, 1181-1186

Abstract | Full text | PDF |
Younger W-Y Yu, Shih-Jen Tsai, Chen-Jee Hong, Tai-Jui Chen, Ming-Chao Chen and Chih-Wei Yang
Association Study of a Monoamine Oxidase A Gene Promoter Polymorphism with Major Depressive Disorder and Antidepressant Response
doi:10.1038/sj.npp.1300785
Neuropsychopharmacology 30, 1719-1723

Abstract | Full text | PDF |
Giampaolo Perna, Elisa Favaron, Daniela Di Bella, Riccardo Bussi and Laura Bellodi
Antipanic Efficacy of Paroxetine and Polymorphism within the Promoter of the Serotonin Transporter Gene
doi:10.1038/sj.npp.1300822
Neuropsychopharmacology 30, 2230-2235

Abstract | Full text | PDF |
Marcella Rietschel, Dieter Naber, Heinrich Oberländer, Rüdiger Holzbach, Rolf Fimmers, Katja Eggermann, Hans-Jürgen Möller, Peter Propping and Markus M Nöthen
Efficacy and Side-Effects of Clozapine: Testing for Association with Allelic Variation in the Dopamine D4 Receptor Gene
doi:10.1016/S0893-133X(96)00090-5
Neuropsychopharmacology 15, 491-496

Abstract | PDF |
S Lanquillon, J-C Krieg, U Bening-Abu-Shach and H Vedder
Cytokine Production and Treatment Response in Major Depressive Disorder
doi:10.1016/S0893-133X(99)00134-7
Neuropsychopharmacology 22, 370-379

Abstract | Full text | PDF |
Ichiro Kusumi, Katsuji Suzuki, Yuki Sasaki, Kensuke Kameda and Tsukasa Koyama
Treatment Response in Depressed Patients with Enhanced Ca Mobilization Stimulated by Serotonin
doi:10.1016/S0893-133X(00)00149-4
Neuropsychopharmacology 23, 690-696

Abstract | Full text | PDF |
Treatment-resistant depression
Charles B Nemeroff, Helen S Mayberg, Scott E Krahl, James McNamara, Alan Frazer, Thomas R Henry, Mark S George, Dennis S Charney and Stephen K Brannan
VNS Therapy in Treatment-Resistant Depression: Clinical Evidence and Putative Neurobiological Mechanisms
doi:10.1038/sj.npp.1301082
Neuropsychopharmacology 31, 1345-1355

Abstract | Full text | PDF |
Harold A Sackeim, A John Rush, Mark S George, Lauren B Marangell, Mustafa M Husain, Ziad Nahas, Christopher R Johnson, Stuart Seidman, Cole Giller, Stephen Haines, Richard K Simpson and Robert R Goodman
Vagus Nerve Stimulation (VNS™) for Treatment-Resistant Depression: Efficacy, Side Effects, and Predictors of Outcome
doi:10.1016/S0893-133X(01)00271-8
Neuropsychopharmacology 25, 713-728

Abstract | Full text | PDF |
Tremor
Yen Kuang Yang, Leann Nelson, Lakshmi Kamaraju, William Wilson and Joseph P McEvoy
Nicotine Decreases Bradykinesia-rigidity in Haloperidol-treated Patients with Schizophrenia
doi:10.1016/S0893-133X(02)00325-1
Neuropsychopharmacology 27, 684-686

Abstract | Full text | PDF |
Triazolam
Miriam Z Mintzer, Roland R Griffiths, Carlo Contoreggi, Alane S Kimes, Edythe D London and Monique Ernst
Effects of Triazolam on Brain Activity During Episodic Memory Encoding: A PET Study
doi:10.1016/S0893-133X(01)00280-9
Neuropsychopharmacology 25, 744-756

Abstract | Full text | PDF |
Tricyclic
Jonathan W Stewart, Patrick J McGrath and Frederic M Quitkin
Do Age of Onset and Course of Illness Predict Different Treatment Outcome among DSM IV Depressive Disorders with Atypical Features?
doi:10.1016/S0893-133X(01)00313-X
Neuropsychopharmacology 26, 237-245

Abstract | Full text | PDF |
Tricyclic antidepressant
Delia M Vázquez, Ramin Eskandari, Andrew Phelka and Juan F López
Impact of Maternal Deprivation on Brain Corticotropin-Releasing Hormone Circuits: Prevention of CRH Receptor-2 mRNA Changes by Desipramine Treatment
doi:10.1038/sj.npp.1300126
Neuropsychopharmacology 28, 898-909

Abstract | Full text | PDF |
X Moreau, R Jeanningros and P Mazzola-Pomietto
Chronic Effects of Triiodothyronine in Combination with Imipramine on 5-HT Transporter, 5-HT1A and 5-HT2A Receptors in Adult Rat Brain
doi:10.1016/S0893-133X(00)00234-7
Neuropsychopharmacology 24, 652-662

Abstract | Full text | PDF |
Tricyclic antidepressants
Pierre Blier, Richard Bergeron and Claude de Montigny
Selective Activation of Postsynaptic 5-HT1A Receptors Induces Rapid Antidepressant Response
doi:10.1016/S0893-133X(96)00242-4
Neuropsychopharmacology 16, 333-338

Abstract | PDF |
Herbert Meltzer, Bijan Bastani, Karuna Jayathilake and Michael Maes
Fluoxetine, but not Tricyclic Antidepressants, Potentiates the 5-Hydroxytryptophan-Mediated Increase in Plasma Cortisol and Prolactin Secretion in Subjects with Major Depression or with Obsessive Compulsive Disorder
doi:10.1016/S0893-133X(96)00280-1
Neuropsychopharmacology 17, 1-11

Abstract | PDF |
Dunja Hinze-Selch, Andreas Schuld, Thomas Kraus, Martin Kühn, Manfred Uhr, Monika Haack and Thomas Pollmächer
Effects of Antidepressants on Weight and on the Plasma Levels of Leptin, TNF-alpha and Soluble TNF Receptors: A Longitudinal Study in Patients Treated with Amitriptyline or Paroxetine
doi:10.1016/S0893-133X(00)00089-0
Neuropsychopharmacology 23, 13-19

Abstract | Full text | PDF |
Nicoletta Galeotti, Alessandro Bartolini and Carla Ghelardini
Role of Gi Proteins in the Antidepressant-like Effect of Amitriptyline and Clomipramine
doi:10.1016/S0893-133X(02)00340-8
Neuropsychopharmacology 27, 554-564

Abstract | Full text | PDF |
Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | previous Previous | Next next
  top go to top

Extra navigation

.
ADVERTISEMENT